{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64001",
      "recalling_firm": "Hospira Inc.",
      "address_1": "275 N Field Dr",
      "address_2": "N/A",
      "postal_code": "60045-2579",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-183-2013",
      "product_description": "0.9% Sodium Chloride Injection USP, 100 mL   Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7984-23,",
      "product_quantity": "325,056 bags",
      "reason_for_recall": "Lack of Assurance of Sterility: There is the potential for solution to leak from the administrative port to the fill tube seal.",
      "recall_initiation_date": "20130108",
      "center_classification_date": "20130307",
      "termination_date": "20150515",
      "report_date": "20130313",
      "code_info": "Lot Number 02-117-JT Exp. 02/13"
    }
  ]
}